Intellia Therapeutics SG&A Expense (Quarterly) Trends

Intellia Therapeutics Inc (NTLA)

21.17 -0.36 (-1.67%) USD | NASDAQ | Apr 24, 16:00

21.70 +0.53 (+2.50%) After-Hours: 06:51

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	28.99M
September 30, 2023	29.40M
June 30, 2023	30.65M
March 31, 2023	27.45M
December 31, 2022	23.63M
September 30, 2022	22.14M
June 30, 2022	22.13M
March 31, 2022	22.40M
December 31, 2021	22.11M
September 30, 2021	18.71M
June 30, 2021	16.68M
March 31, 2021	13.59M
December 31, 2020	10.76M
September 30, 2020	10.57M
June 30, 2020	11.53M
March 31, 2020	11.31M
December 31, 2019	8.976M
September 30, 2019	8.431M

Date	Value
June 30, 2019	13.12M
March 31, 2019	10.53M
December 31, 2018	8.708M
September 30, 2018	8.27M
June 30, 2018	7.805M
March 31, 2018	7.406M
December 31, 2017	10.21M
September 30, 2017	5.711M
June 30, 2017	6.369M
March 31, 2017	5.732M
December 31, 2016	5.118M
September 30, 2016	4.705M
June 30, 2016	3.729M
March 31, 2016	3.246M
December 31, 2015	2.809M
September 30, 2015	1.531M
June 30, 2015	2.833M
March 31, 2015	1.11M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

8.431M

Minimum

Sep 2019

30.65M

Maximum

Jun 2023

18.56M

Average

18.71M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks